Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Monoclonal Antibodies Targeting Human DNA Polymerase beta, a DNA Repair Enzyme
Case ID:
TAB-2401
Web Published:
12/6/2022
Available for licensing are monoclonal antibodies targeting human DNA polymerase beta (Pol B). Pol B is a constitutively expressed "housekeeping" enzyme that plays a role in base excision repair (BER), a cellular defense mechanism that repairs DNA base damage and loss. Aberrant Pol B expression is associated with genomic instability indicating that Pol B is required for DNA maintenance, replication and recombination.
These antibodies can be utilized to elucidate BER's mechanism of action and Pol B's structure and function. Moreover, the antibodies can be used to detect Pol B in samples with a variety of techniques including immunoblotting, ELISA, immunoprecipitation, and immunohistochemistry.
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Direct Link:
https://canberra-ip.technologypublisher.com/tech?title=Monoclonal_Antibodies_ Targeting_Human_DNA_Polymerase_beta%2c_a_DNA_Repair_Enzyme
Keywords:
AC5XXX
ACXXXX
ANTIBODY
AXXXXX
CC2XXX
CCXXXX
CDXXXX
CXXXXX
DNA
DNA polymerase
DNA polymerase beta
monoclonal
Monoclonal Antibody
monoclonal antibody based assays
polymerase
Bookmark this page
Download as PDF
For Information, Contact:
Kevin Chang
Licensing and Patenting Manager
NIH Technology Transfer
240-276-6910
changke@mail.nih.gov